Depressive disorders and intravenous drug use in chemsex context

• Published in: European psychiatry 2024-08, Vol.67 (S1), p.S322-S322
• Main Authors: J Curto Ramos, A Rodríguez Laguna, Barrio, P, Ibarguchi, L, García, A, Azqueta, I, Segal, H Dolengevich
• Format: Article
• Language: English
• Subjects: Drug use; Mental disorders; Mental health
• ISSN: 0924-9338; 1778-3585
• DOI: 10.1192/j.eurpsy.2024.668

IntroductionSeveral studies have called atention to the mental health disorders associated with chemsex -the intentional use of drugs before or during sexual intercourse GBMSM (gay, bisexual and men who have sex with men) population-. Sexualized intravenous drug use is also known as slam or slamsex. There are few studies that analyze the mental health differences between intravenous drug users compared to non-intravenous drug users in chemsex context.ObjectivesWe aim to describe the mental health outcomes including current and past depressive disorders diagnosis in a sample of users with sexualized drug use (chemsex) attended by the non-governmental organization Apoyo Positivo in the program “Sex, Drugs and You” and to compare the differences of current and previous diagnosis of depressive disorders between intravenous drug users compared to non-intravenous drug users.MethodsA cross-sectional descriptive analysis of a sample of users attended by the non-govenrmental organization Apoyo Positivo in the program “Sex, Drugs and You” between 2016-2019 was performed.ResultsWe included 217 participants. Current or past diagnosis of depression was found in 137 participants. Depressive disorders were significantly higher in the intravenous drug use group compared to the non-intravenous drug use group (p